 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| PZOO Holding Double Digit % Gains on Huge Volume |
|
 Hot Stock to Watch |
Company: Pazoo Inc. (OTCQB: PZOO)
|
Last:
Price: 0.0066
Change (%): + 0.0006 (10.00)
Volume: 41,490,336 |
 |
Pazoo's Harris Lee to Take Over Operations at Colorado Marijuana Testing Facility
WHIPPANY, N.J., April 1, 2015 (GLOBE NEWSWIRE) - Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK) is proud to announce that wholly owned subsidiary, Harris Lee, LLC, has entered into a Binding Letter of Intent with Front Range, the Steep Hill licensee for Colorado, to purchase the assets to operate Steep Hill Colorado, a marijuana testing laboratory located in Denver, CO. Additionally, Front Range will transfer all assignable rights and licenses to Harris Lee.
Harris Lee will take 100% ownership of this fully functional, revenue generating facility no later than April 30, 2015. All necessary permits, licenses, government approvals, equipment and leases required to operate this facility will be transferred to Harris Lee.
In the short time since Pazoo acquired full ownership of Harris Lee on January 14, 2015, the company has been pleased to announce two separate expansions with Steep Hill Labs in Oregon and now Colorado. Including MA & Associates’ facility in Las Vegas, Pazoo has now formed a Steep Hill footprint in three states within the past six months.
“This acquisition, initiated by Steep Hill Labs, further reinforces the commitment between our two great companies,” stated David Cunic, Co-CEO of Pazoo. “We look forward to continued growth and expansion with our friends at Steep Hill.”
For more information on Steep Hill Colorado, please visit: http://steephilllab.com/colorado/
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
